DR. MARCUS BUTLER

DR. MARCUS BUTLER

CLINICAL HEAD, IMMUNE PROFILING TEAM

Dr. Marcus Butler is motivated to help patients, and, in his own words, cautiously optimistic about immunotherapy. For Dr. Butler, the challenge he currently faces is determining how immunotherapy can be tailored to treat each type of cancer effectively. He’s excited about the possibilities of his work in adoptive T-cell therapy.

In his lab, Dr. Butler and his team work to engineer an immune response by taking cells from a patient’s own immune system and modifying them to fight cancer more effectively. Essentially, they supercharge the immune system.

Dr. Butler was drawn to The Princess Margaret for its international reputation and commitment to immunotherapy as a powerful tool to treat cancer. He was recruited from the Dana-Farber Cancer Institute.

The collaborative culture at the Cancer Centre inspires Dr. Butler to push forward with innovative research. “This is the kind of environment that anyone would want to be in to help move the field forward.”


IMMUNOTHERAPY


THE CANCER WARRIOR UNLEASHED
Special feature publication. Read it online now or order a free magazine.
ORDER FREE COPY
READ ONLINE